Back
SoftBank Corp. - ADR Vs. Nektar Therapeutics Industry Stock Comparison
Buy
79
SOBKY
SoftBank Corp. - ADR
Last Price:
$16.30
Seasonality Move:
-3.68%
Buy
62
NKTR
Nektar Therapeutics
Last Price:
$27.26
Seasonality Move:
4.65%
Buy
79
SoftBank Corp. - ADR (SOBKY)
is a Buy
Is SoftBank Corp. - ADR a Buy, Sell or Hold?
-
The current SoftBank Corp. - ADR [SOBKY] share price is $16.30. The Score for SOBKY is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
SOBKY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $27.26. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SOBKY Stock Price Chart
What is SoftBank Corp. - ADR's stock price today?
-
The SoftBank Corp. - ADR share price today is $16.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SOBKY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $27.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
SOBKY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.98 | Buy |
Relative Strength Index (14 RSI): | 72.97 | Buy |
Chaikin Money Flow: | 17124 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.5 - 15.72) | Buy |
Bollinger Bands (100): | (14.46 - 15.52) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 66.02 | Buy |
Chaikin Money Flow: | -23288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.49 - 25.51) | Buy |
Bollinger Bands (100): | (8.3 - 22.66) | Buy |
SOBKY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.9 | Buy |
20-day SMA: | 15.22 | Buy |
50-day SMA: | 15.13 | Buy |
200-day SMA: | 14.02 | Buy |
8-day EMA: | 15.45 | Buy |
20-day EMA: | 11.81 | Buy |
50-day EMA: | 6.66 | Buy |
200-day EMA: | 2.02 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.13 | Buy |
20-day SMA: | 23.8 | Buy |
50-day SMA: | 20.82 | Buy |
200-day SMA: | 15.1 | Buy |
8-day EMA: | 24.9 | Buy |
20-day EMA: | 23.86 | Buy |
50-day EMA: | 21.15 | Buy |
200-day EMA: | 16.63 | Buy |
SoftBank Corp. - ADR Earnings Growth & SOBKY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
SoftBank Corp. - ADR Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |